New clinical trial shows 39% reduction of ventilator-associated pneumonia with Bactiguard’s endotracheal tube
A new study has been published on Bactiguard’s endotracheal tube (BIP ETT) that shows a significant reduction of both ventilator-associated pneumonia (VAP) and antibiotic use. This randomized controlled study on 180 intensive care patients was published in the Balcan Medical Journal, in March 2022. The main objective of the study was to evaluate...